Enanta Pharmaceuticals Inc (ENTA)
Stock-Based Compensation
$3.68M
Quarterly · Period ending: · USD
ENTA Stock-Based Compensation
Latest reported$3.68Mperiod ending
Latest reported$3.68Mperiod ending
ENTA Quarterly Stock-Based Comp ($72.00K → $3.68M)
Quarterly stock-based compensation
High-resolution chart · PNG
ENTA stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 3,683,000 | |
| 3,748,000 | |
| 3,810,000 | |
| 4,034,000 | |
| 4,177,000 | |
| 4,688,000 | |
| 5,666,000 | |
| 7,718,000 | |
| 5,417,000 | |
| 5,561,000 | |
| 8,099,000 | |
| 6,716,000 | |
| 6,998,000 | |
| 7,363,000 | |
| 7,139,000 | |
| 6,833,000 | |
| 7,603,000 | |
| 6,471,000 | |
| 6,062,000 | |
| 5,353,000 | |
| 5,475,000 | |
| 5,280,000 | |
| 4,883,000 | |
| 4,745,000 | |
| 4,754,000 | |
| 4,978,000 | |
| 5,098,000 | |
| 4,512,000 | |
| 4,164,000 | |
| 4,707,000 | |
| 5,843,000 | |
| 4,110,000 | |
| 4,025,000 | |
| 3,590,000 | |
| 4,120,000 | |
| 3,210,000 | |
| 3,102,000 | |
| 3,492,000 | |
| 3,267,000 | |
| 2,510,000 | |
| 2,470,000 | |
| 2,382,000 | |
| 1,992,000 | |
| 1,797,000 | |
| 1,584,000 | |
| 1,429,000 | |
| 1,028,000 | |
| 795,000 | |
| 776,000 | |
| 752,000 | |
| 359,000 | |
| 286,000 | |
| 239,000 | |
| 257,000 | |
| 281,000 | |
| 243,000 | |
| 95,000 | |
| 31,000 | |
| 55,000 | |
| 72,000 |